CELEX: 62018TB0337
Language: en
Date: 2018-08-24 00:00:00
Title: Case T-337/18 R and T-347/18 R: Order of the President of the General Court of 24 August 2018 — Laboratoire Pareva and Biotech3D v Commission (Interim relief — Regulation (EU) No 528/2012 — Biocidal products — Active substance PHMB (1415; 4.7) — Approval refused — Application for interim measures — Prima facie case — Weighing up of competing interests)

5.11.2018   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 399/35
            
         
      Order of the President of the General Court of 24 August 2018 — Laboratoire Pareva and Biotech3D v Commission
      (Case T-337/18 R and T-347/18 R)
      ((Interim relief - Regulation (EU) No 528/2012 - Biocidal products - Active substance PHMB (1415; 4.7) - Approval refused - Application for interim measures - Prima facie case - Weighing up of competing interests))
      (2018/C 399/48)
      Language of the case: English
      
         Parties
      
      
         Applicant in case T-337/18 R: Laboratoire Pareva (Saint-Martin-de-Crau, France) (represented by: K. Van Maldegem and S. Englebert, lawyers)
      
         Applicants in case T-347/18 R: Laboratoire Pareva (Saint-Martin-de-Crau, France) and Biotech3D Ltd & Co. KG (Gampern, Austria) (represented by: K. Van Maldegem and S. Englebert, lawyers)
      
         Defendant: European Commission (represented by: R. Lindenthal and K. Mifsud-Bonnici, acting as Agents)
      
         Re:
      
      Application pursuant to Articles 278 and 279 TFEU seeking suspension of operation of Commission Implementing Decision (EU) 2018/619 of 20 April 2018 not approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 1, 5 and 6 (OJ 2018 L 102, p. 21) and Commission Implementing Regulation (EU) 2018/613 of 20 April 2018 approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 2 and 4 (OJ 2018 L 102, p. 1), and the adoption of any other appropriate interim measures.
      
         Operative part of the order
      
      
                  1.
               
               
                  Cases T-337/18 R and T-347/18 R are joined for the purpose of the present order.
               
            
                  2.
               
               
                  The applications for interim measures are dismissed.
               
            
                  3.
               
               
                  The costs are reserved.